HomeRLYB • NASDAQ
add
Rallybio Corp
Previous close
$1.83
Day range
$1.78 - $1.89
Year range
$1.23 - $9.14
Market cap
69.20M USD
Avg Volume
3.12M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 21.11M | 23.53% |
Net income | -20.24M | -24.93% |
Net profit margin | — | — |
Earnings per share | -0.50 | -8.70% |
EBITDA | -21.08M | -23.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 109.93M | -34.95% |
Total assets | 115.62M | -35.92% |
Total liabilities | 9.44M | -15.13% |
Total equity | 106.18M | — |
Shares outstanding | 37.81M | — |
Price to book | 0.65 | — |
Return on assets | -42.43% | — |
Return on capital | -45.78% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -20.24M | -24.93% |
Cash from operations | -11.64M | 23.71% |
Cash from investing | 16.91M | 155.18% |
Cash from financing | 72.00K | -99.86% |
Net change in cash | 5.34M | 1.70% |
Free cash flow | -4.58M | 51.27% |
About
Founded
2018
Headquarters
Website
Employees
43